Predicting Different Recurrence Risk in HNSCC Using Circulating Inflammatory and T-Cell Biomarkers. Gili R, Camerino PL, Lalli L, Bellini E, et al. Laryngoscope 2026;136:2189-2198.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gili R, Camerino PL, Lalli L, Bellini E, et al. Predicting Different Recurrence Risk in HNSCC Using Circulating Inflammatory and T-Cell Biomarkers. Laryngoscope 2026;136:2189-2198.
PMID: 41431858